SPOTLIGHT: Is Aspen right to abandon lenacapavir for an unproven HIV prevention pill?
Source: Daily MaverickClick here to open the original in a new window ↗
By Catherine Tomlinson for Spotlight23/09/2026 às 09:50273 views
📷 Image protected by copyright of Daily Maverick. See at Open original ↗
Aspen Pharmacare has announced that it will not be manufacturing the lenacapavir HIV prevention injection, and that it will instead focus on producing alimatravir, an experimental HIV prevention pill.…
Full article at
Daily Maverick
⚖️ Only excerpts are republished (fair use).
Was this news useful?
Debates 0
Be the first to contribute to the debate.
Share your information and promote your argument
Do not hesitate to publish information or data that may be positive or useful.
To join the debate, log in or create a free account.